Article
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United States 2015-2017.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Jun 2021
Karlowsky James A, Lob Sibylle H, Raddatz Janet, DePestel Daryl D, Young Katherine, Motyl Mary R, Sahm Daniel F
Abstract excerpt
BACKGROUND: Multidrug-resistant (MDR) bacteria are frequently defined using the criteria established by Magiorakos et al [Clin Microbiol Infect 2012;18:268-81]. Difficult-to-treat resistance (DTR) [Kadri et al, Clin Infect Dis 2018;67:1803-14] is a novel approach to defining resistance in gram-negative bacilli focusing on treatment-limiting resistance to first-line agents (all β-lactams and fluoroquinolones)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.